slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
211,861-211,890 of 319,975
03
The slide uses a high-level mission statement as the primary anchor for the presentation.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit
04
The slide uses a patient persona (Crystal) to humanize the clinical goals of minimizing burden and restoring quality of life.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit
05
argenx SE | Investor Presentation Deck | 26 slidesargenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit
06
The slide uses a hub-and-spoke visual arrangement with a central image of a patient.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
07
The slide uses a central circular image overlaying four surrounding text boxes containing key performance indicators.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
08
The slide uses a circular, iterative process diagram to suggest continuous growth.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
09
The slide uses a 3D-like coordinate system to show expansion vectors.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
10
The slide uses a map to visualize global reach, supplemented by two tables detailing approval dates for two different products.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
11
The slide uses a hub-and-spoke visual metaphor to link the drug class to various autoantibody targets.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
12
The slide uses a pyramid structure to imply growth and scale across multiple disease areas.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
13
Kaplan-Meier curve shows probability of no relapse over 48 weeks for Vyvgart Hytrulo vs Placebo.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
14
The slide uses a split-screen layout: left side details the mechanism of action and current status of the MMN study, right side details the future roadmap.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
15
Includes a biological mechanism diagram on the left and a clinical trial roadmap on the right.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
16
The slide uses a circular icon-based layout to categorize medical conditions under four main therapeutic areas.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
17
The slide uses a hub-and-spoke style layout to represent partnerships, though it is not a formal framework.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
18
argenx SE | Investor Presentation Deck | 26 slidesargenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
19
The slide uses a hub-and-spoke diagram to represent corporate values.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
20
The chart uses a horizontal bar format to represent clinical trial phases (Preclinical to Commercial) for multiple indications under four main programs.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
21
Clinical trial design slide showing a timeline of visits and dosing phases.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
22
The slide outlines a clinical trial protocol using a timeline-based process flow.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
23
Clinical trial design schematic showing 2:1 randomization between Efgartigimod and Placebo over 24 weeks.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
24
The slide uses a process flow diagram to illustrate the clinical trial structure.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
25
The slide outlines a multi-phase trial structure with specific cohorts (IMNM, ASyS, DM) and a GO/NO-GO decision point.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
26
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
01
Astra | Results Presentation Deck | 18 slidesAstra | Results Presentation Deck | 18 slides · Astra
Conference presentation Investor relations 1 hit
02
Astra | Results Presentation Deck | 18 slidesAstra | Results Presentation Deck | 18 slides · Astra
Conference presentation Investor relations 1 hit
03
Astra | Results Presentation Deck | 18 slidesAstra | Results Presentation Deck | 18 slides · Astra
Conference presentation Investor relations 1 hit
04
Astra | Results Presentation Deck | 18 slidesAstra | Results Presentation Deck | 18 slides · Astra
Conference presentation Investor relations 1 hit
05
The slide uses a split-screen visual approach to represent the two core business units.Astra | Results Presentation Deck | 18 slides · Astra
Conference presentation Investor relations 1 hit
06
Astra | Results Presentation Deck | 18 slidesAstra | Results Presentation Deck | 18 slides · Astra
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit